Prostate cancer (PCa) is the most common cancer in men (excluding non melanoma skin cancer) in the UK with over 40,000 cases diagnosed each year (CancerResearchUK [2015]). However, for some men with early stage PCa that is confined to the prostate the disease may never be life threatening and can follow and indolent course which…
UCLA scientists have identified a new mechanism that delivers a key substance that fuels the growth of pancreatic and prostate cancer cells, a finding that offers new hope in the fight against two of the deadliest forms of the disease. Cancer cells require high amounts of the sugar glucose to survive and grow, and long-standing…
Democratic Sen. Bill Nelson of Florida will undergo prostate cancer surgery at a local hospital Monday, his office said Thursday. Doctors found the cancer during a routine exam, according to a release from his office. It said Nelson had no symptoms and “extensive” scans showed no evidence the cancer has spread outside the prostate. Nelson,…
In the analysis of 10,472 men from 1990 to 2013, use of surveillance for low-risk disease rose sharply in 2010 through 2013, to 40% of cases. Use of surveillance had previously remained low, at between 7% and 14%, from 1990 through 2009. Dr. Matthew Cooperberg did the study with Dr. Peter Carroll, both of the…
For the first time, a single molecule has been identified that could be central to the mechanism of spread by prostate cancer. The findings could lead to a new prostate cancer drug target. The study is published in the journal Cancer Cell and was completed by researchers from the Thomas Jefferson University in Philadelphia, PA.…
FOR years, research on prostate cancer has sought an approach to screening that is more individualized than a one-size-fits-all measurement of the level of prostate-specific antigen in a man’s blood. These efforts are now paying off. That’s why it’s time to re-evaluate the nation’s current approach to prostate cancer. Even though we anticipate 221,000 new…
The 2015 update of the guidelines for prostate cancer from the National Comprehensive Cancer Network (NCCN) marks the 20th annual edition of the guidance. The update contains three major changes, which are related to imaging, molecular testing, and the systemic treatment of castration-resistant disease, said James Mohler, MD, who chairs the NCCN panel for prostate…
The U.S. Preventive Services Task Force (USPSTF) recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in…